Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

View basket
☰

Tofisopam

Tofisopam
In stock
50mg
from 21,40 £
Strength
Pack size — the bigger the pack, the cheaper the tablet
25,68 £21,40 £
2,14 £ per tablet

In brief

  • Tofisopam is an anti-anxiety medicine with an unusual 2,3-benzodiazepine structure, prescribed in some central and eastern European countries.
  • 50 mg tablets, offered in quantities between 10 and 180.
  • Not licensed in the UK, so there is no British SmPC or patient leaflet; any use is a matter for an individual prescriber.

Tofisopam among the anxiolytics

Tofisopam is an anxiolytic, a medicine intended to ease nervous tension, inner restlessness and the physical signs of anxiety. Chemically it is a 2,3-benzodiazepine, whereas the benzodiazepines prescribed in Britain, diazepam and lorazepam among them, are 1,4-benzodiazepines. Manufacturers describe it as less sedating than those older drugs, but that is their own claim and has not been examined by a UK regulator. Its use is concentrated in central and eastern Europe.

50 mg tablets and pack choice

Tofisopam is supplied as 50 mg tablets, and the listing offers 10, 20, 30, 60, 90, 120 or 180. This stock is imported, so the outer box and any enclosed leaflet come from the overseas manufacturer and may not be in English. The dose and the length of a course should be agreed with the prescriber rather than taken from foreign packaging. Keep the strips dry, at room temperature and safely away from children.

What being unlicensed means in Britain

There is no entry for this medicine on the electronic medicines compendium, the database of SmPCs and leaflets for products licensed in the UK. In other words, the MHRA has not evaluated its quality, safety or effectiveness, and no UK-approved indication, dose or warning list exists. A doctor can still decide to prescribe an unlicensed medicine for an individual patient, but the prescriber carries more responsibility for that choice and should explain it beforehand.

How the NHS approaches anxiety

For generalised anxiety disorder, NICE sets out care in steps. The first step is explanation plus watchful follow-up; next comes low-intensity support like guided self-help; after that, cognitive behavioural therapy, applied relaxation or a medicine. Where a medicine is chosen, NICE puts sertraline at the top of the list. Benzodiazepines are reserved for short-term use in a crisis because tolerance and dependence can develop, and antipsychotics are not recommended for this condition in primary care. These licensed routes are worth discussing with a GP first, and in England many people can refer themselves to NHS Talking Therapies for psychological treatment.

Health details the prescriber should know

Since tofisopam lacks a UK SmPC, nobody in Britain has published an approved set of contraindications or interactions for it. It is sensible to mention any previous reaction to a benzodiazepine, breathing difficulties or sleep apnoea, liver or kidney problems, a past dependence on alcohol or other substances, and pregnancy, plans to conceive or breastfeeding. Other sedating substances, including alcohol, sleeping tablets, opioid painkillers and drowsy antihistamines, may add to any calming effect, so bring a complete list of medicines and herbal products. Older adults can be more sensitive to anything that dulls alertness.

Alertness, mood and reporting problems

Hold off driving or using tools and machinery until you know how the tablets affect your concentration. Because no UK side-effect list exists, tell the prescriber about anything unexpected, and seek help quickly if you feel more agitated, confused or low in mood. Suspected reactions to any medicine, licensed or not, can be reported to the MHRA via the Yellow Card scheme. Whether tofisopam is appropriate for you is for your doctor to decide.

Related products